Free Republic 3rd Quarter Fundraising Target: $85,000 Receipts & Pledges to-date: $20,803
24%  
Woo hoo!! And the first 24% is in!! Thank you all very much!!

Keyword: pharma

Brevity: Headers | « Text »
  • Masters Pharmaceutical Responds To FDA On Ohio Drug Seizures

    05/25/2014 7:19:26 PM PDT · by mgist · 11 replies
    pharmaceutical O nline ^ | 5/23/14 | Root
    Masters Pharmaceutical Responds To FDA On Ohio Drug Seizures By Cyndi Root Masters Pharmaceutical issued a press release disputing the Food and Drug Administration’s (FDA) position on the raid at Master’s subsidiary RXTPL. The FDA and U.S. Marshalls went to RXTPL’s logistics facility in Fairfield, Ohio on Thursday, May 15, 2014. The government had a search warrant based on a November 2013 inspection at Ascend Laboratories, which showed the use of unapproved drugs. Masters says that RXTPL cooperated with the government in quarantining the drugs at the facility. However, Masters takes issue with the FDA press release that states that...
  • ObamaCare’s Crony Capitalism: Worse than We Thought

    11/11/2013 2:18:16 PM PST · by SJackson · 11 replies
    Commentary Magazine ^ | 11.07.2013 | Seth Mandel
    At times it seems like the sheer magnitude of bad news about ObamaCare can redound to its own benefit. It’s easy for individual pieces of bad news to get lost in the sea of failure that has characterized the Obama administration’s signature “achievement.” That might be the case with the most important story to appear about ObamaCare this week, from Tuesday’s edition of the New York Times. The paper reported that the Obama administration has ruled that the federal health-care program be exempted from the category of laws considered “federal health care programs.” Now, this is obviously dishonest: the federal...
  • Dirty medicine (Indian generic pharma fined $500m for fraudulent trials data)

    05/24/2013 4:21:02 AM PDT · by Zhang Fei · 2 replies
    Fortune ^ | May 15, 2013: 9:03 AM ET | Katherine Eban
    On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. (snip) His boss, Dr. Rajinder Kumar, Ranbaxy's head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. (snip) Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then 35, an American-trained engineer and a naturalized U.S. citizen, had worked at Bristol-Myers Squibb (BMY)...
  • Nationwide drug shortage problem increasing

    03/10/2012 10:46:01 AM PST · by aimhigh · 18 replies
    WNEM.com ^ | 03/10/2012 | CNN/WCBS
    A nationwide drug shortage that's dogging the food and drug administration is hitting home with first responders. For emergency medical technicians, shortages can mean the difference between life and death. Nationwide, anti-seizure drugs including intravenous Valium, Versed, and Ativan are among the dozens of drugs - including cancer treatments - that are in short supply.
  • THC, HMA, OREX, HCA, LNCR-Unusual Volume (h'care stocks +unusual pre-decision trades)Read more:

    06/29/2012 4:31:32 PM PDT · by STARWISE · 8 replies
    The Stock Market Watch ^ | 6-28-12 | Alex Fredericks
    We have found the following stocks had unusual volume spikes on Thursday, June 28, 2012. Tenet Healthcare Corp. (NYSE:THC) had a 86.9% volume spike trading 40,717,900 shares. THC’s 30-day average volume is 5,335,410. Shares closed at $5.25 +6.71%. Tenet Healthcare Corporation is an investor-owned health care services company whose subsidiaries and affiliates mainly operate acute care hospitals, ambulatory surgery centers, diagnostic imaging centers and related health care facilities. Health Management Associates (NYSE:HMA) had a 86.1% volume spike trading 24,950,900 shares. HMA’s 30-day average volume is 3,461,860. Shares closed at $7.49 +11.79%. Health Management Associates, Inc and its subsidiariesprovide health care...
  • Agenda 21 - What Is It? Apparently is is a plan to reduce the population

    06/22/2011 12:44:33 PM PDT · by TEXOKIE · 655 replies
    Vanity | Various
    Several people have become interested in a quite controversial topic called "AGENDA 21." They have requested being on a ping list for this topic. While I do not have time to do a thorough treatment of this subject, nor am I in any way an expert, I am willing at least for a time,to ping people as I run across articles which might pertain to this concern. It might be good to start with an examination of just what it is or might be. To kick this discussion and exploration off,I did a Google search (just for fun) on "Agenda...
  • Gingrich camp's 'last word' on Freddie Mac - Will not release records

    11/17/2011 11:58:43 AM PST · by Fred · 65 replies
    (CNN) - Former House Speaker Newt Gingrich will not release more Freddie Mac-related documents, according to campaign spokesman R.C. Hammond. Though the contender for the 2012 GOP presidential nomination said Wednesday that his campaign would "do what they can" to release more information about payments he received as a consultant from the government-backed mortgage group, Hammond backtracked later in the evening. When asked via email whether the campaign would release more Freddie Mac-related documents or if a fact sheet it released in the afternoon was the last word on the issue, Hammond responded to CNN, "last word."
  • Gingrich made big bucks pushing corporate welfare (BIG PHARMA)

    11/16/2011 6:54:03 PM PST · by Fred · 46 replies
    Washington Examiner ^ | 11/16/11 | Tom Carney
    Newt Gingrich spent the last decade being paid by big business to convince conservatives to support big-government policies that would profit his clients. Gingrich's consulting firm racked up $1.6 million in fees from the government-sponsored enterprise Freddie Mac, we learned this week from Bloomberg News. Gingrich's job was to help Freddie Mac win over conservatives to this market-distorting, bubble-fueling, housing-subsidy entity, which is now officially owned by the federal government. We also know that Growth Energy, an ethanol lobby, paid $312,500 to the Gingrich Group in 2009, according to the group's tax filing. Growth Energy lobbies to preserve many ethanol...
  • If you're sensitive to scorpion stings, you don't want to read this

    11/14/2011 6:15:36 PM PST · by BlazingArizona · 22 replies
    Arizona ^ | 11/14/11 | Ken Alltucker
    (Cannot quite due to copyright restrictions) Read here: http://www.a azcentral.com/news/articles/2011/11/10/20111110scorpion-drug-cost.html#ixzz1dje2uG1i
  • China and India Making Inroads in Biotech Drugs

    09/20/2011 1:17:35 AM PDT · by Cronos · 5 replies
    New York Times ^ | 18 Sep 2011 | Gardiner Harris
    Chinese and Indian drug makers have taken over much of the global trade in medicines and now manufacture more than 80 percent of the active ingredients in drugs sold worldwide. But they had never been able to copy the complex and expensive biotech medicines increasingly used to treat cancer, diabetes and other diseases in rich nations like the United States — until now. These generic drug companies say they are on the verge of selling cheaper copies of such huge sellers as Herceptin for breast cancer, Avastin for colon cancer, Rituxan for non-Hodgkin’s lymphoma and Enbrel for rheumatoid arthritis. Their...
  • Pfizer CEO Jeffrey Kindler Resigns Even Sooner Than We Predicted (Obamacare sellout)

    12/06/2010 9:14:15 AM PST · by jazusamo · 9 replies
    National Legal & Policy Center ^ | December 6, 2010 | Peter Flaherty
      Pfizer CEO Jeffrey Kindler has unexpectedly announced his resignation. NLPC recently filed a shareholder proposal with Pfizer critical of the company's deal with the White House to support ObamaCare. We foresaw Kindler's retirement in the resolution's supporting statement: If ObamaCare fails to control health care costs, as several studies now suggest, the government will seek savings through price controls. Shareholders ultimately will lose. Perhaps Kindler plans to retire before Pfizer is required to sell its products for less than the cost of production. We were more prescient than we realized.Kindler, who is only 55, cited the "extremely demanding"...
  • Docs on Pharma Payroll Have Blemished Records, Limited Credentials

    10/19/2010 10:55:24 AM PDT · by JoeProBono · 3 replies
    propublica ^ | Oct. 18, 2010, | Charles Ornstein
    The Ohio medical board concluded [1] that pain physician William D. Leak had performed “unnecessary” nerve tests on 20 patients and subjected some to “an excessive number of invasive procedures,” including injections of agents that destroy nerve tissue. Yet the finding, posted on the board’s public website, didn’t prevent Eli Lilly and Co. from using him as a promotional speaker and adviser. The company has paid him $85,450 since 2009. In 2001, the U.S. Food and Drug Administration ordered [2] Pennsylvania doctor James I. McMillen to stop “false or misleading” promotions of the painkiller Celebrex, saying he minimized risks and...
  • Big Pharma scores big win - Medicinal herbs will disappear in EU

    09/21/2010 9:43:24 PM PDT · by MamaDearest · 32 replies
    gala-health.com ^ | September 12, 2010 | Heidi Stevenson
    It's almost a done deal. We are about to see herbal preparations disappear, and the ability of herbalists to prescribe them will also be lost. Big Pharma has almost reached the finish line of its decades-long battle to wipe out all competition. As of 1 April 2011—less than eight months from now—virtually all medicinal herbs will become illegal in the European Union. The approach in the United States is a bit different, but it's having the same devastating effect. The people have become nothing more than sinks for whatever swill Big Pharma and Agribusiness choose to send our way, and...
  • Child’s Ordeal Shows Risks of Psychosis Drugs for Young

    09/02/2010 10:53:51 AM PDT · by Wolfie · 48 replies
    NY Times ^ | Sept. 1, 2010
    Child’s Ordeal Shows Risks of Psychosis Drugs for Young OPELOUSAS, La. — At 18 months, Kyle Warren started taking a daily antipsychotic drug on the orders of a pediatrician trying to quell the boy’s severe temper tantrums. Thus began a troubled toddler’s journey from one doctor to another, from one diagnosis to another, involving even more drugs. Autism, bipolar disorder, hyperactivity, insomnia, oppositional defiant disorder. The boy’s daily pill regimen multiplied: the antipsychotic Risperdal, the antidepressant Prozac, two sleeping medicines and one for attention-deficit disorder. All by the time he was 3. He was sedated, drooling and overweight from the...
  • VANITY: Bizarre statement about Pharmas creating & spreading new artificial viruses & diseases

    05/03/2010 5:21:40 AM PDT · by SilvieWaldorfMD · 71 replies · 921+ views
    Self | 5/3/10
    A psychotic friend of my sister's stated recently that Pharmaceutical Comapnies are "creating and spreading new artificial viruses and diseases... in an effort to increase their profits!" I asked her what kind of evidence she had to support this, and I've been so far met with silence (she's busy Googling & researching this). As she re-adjusts her "tin-foil hat", I wanted to ask my FR friends what they think about this issue and how you would respond to such a blatantly false statement?
  • Big Pharma Loves Obama Care

    03/22/2010 6:58:30 AM PDT · by ICAB9USA · 25 replies · 765+ views
    patientpowernow.org ^ | 3/18/10 | Brian Schwartz
    From Tim Carney’s article in the Washington Examiner, Dems tap drug maker millions for PhRMA-friendly bill: Of all the single-industry lobbies in Washington, the largest is the Pharmaceutical Researchers and Manufacturers of America. PhRMA spent $26.2 million on lobbying last year — that’s nearly three times as much as the insurance lobby, America’s Health Insurance Plans, which spent $8.9 million. If you include individual companies’ lobbying, pharmaceuticals blow away the competition, beating all other industries by 50 percent, according to data at the Center for Responsive Politics. Given this Big Pharma clout, it’s unsurprising that the bill Obama’s whipping for...
  • One Grand Deal Too Many Costs (pharma) Lobbyist (Billy Tauzin) His Job

    02/13/2010 9:16:37 AM PST · by reaganaut1 · 9 replies · 531+ views
    New York Times ^ | February 13, 2010 | David D. Kirkpatrick and Duff Wilson
    ... Mr. Tauzin, 66, will retreat, to contemplate the apparent collapse of the grandest in a career of fearless deals — a pact to trade the drug industry’s political support for favorable terms under President Obama’s proposed health care overhaul. Mr. Tauzin is leaving his $2 million-a-year job as the top lobbyist for the drug industry amid complaints from drug makers that he bargained away their profits too cheaply, spent too much in his $150 million advertising campaign to sell the overhaul and miscalculated in his assessment that the passage of the legislation was all but inevitable. Other drug industry...
  • Vanity: Pharma and the Rope (Big Pharma Ads for Zerocare)

    01/12/2010 4:38:45 PM PST · by C19fan · 1 replies · 166+ views
    December 11,2010 | Me
    I was just watching Fox News and they had an ad telling how great ObamaCare is and the 2 donkey VA Senators are so wonderful for supporting it. I noticed the ad was sponsored by Pharma which as most freepers know made a deal with Zero paying for these ads. I hope is this passes, which I think it will given my pessimistic nature, some donkey politician comes back in a few years and slaps price controls, etc on the drug industry. They have a price for selling their souls. I can't but help think of the infamous quote by...
  • Drug Industry Girds for Rise in Its Share of Overhaul

    12/23/2009 6:26:31 AM PST · by reaganaut1 · 2 replies · 233+ views
    New York Times ^ | December 22, 2009 | David D. Kirkpatrick
    Facing last-minute liberal resistance in Congress, the drug industry is bracing for an increase in its share of the cost of the proposed health care overhaul beyond the $80 billion over 10 years that it had negotiated with the White House, industry lobbyists say. ... Now, after narrowly beating back some Senate proposals to extract far more and facing similar demands from House leaders, the drug makers acknowledge that they may have to renegotiate, several drug lobbyists said, speaking on the condition of anonymity because the overhaul legislation is not yet final. ... Lobbyists for the health insurance industry, meanwhile,...
  • Did Barack Obama Reward Financially Reward ABC News For the OBAMACARE Prime-time Special?

    12/18/2009 8:05:01 AM PST · by Shellybenoit · 4 replies · 565+ views
    National Center/The Lid ^ | 12/18/09 | The Lid
    The health care debate began for real in June when ABC devoted an entire hour to Obamacare in a special edition of ABC's Prime time hosted anchor Charlie Gibson and (now incoming anchor) Diane Sawyer. Called "Questions for the President: Prescription for America" the special aired on June 24, 2009, from the East Room of the White House. Basically Obama was given solo airtime to pitch his health care agenda both in prime time and later that evening on Nightline. To make matters worse, Conservatives for Patients' Rights (CPR) a group that opposes Obamacare tried to air commercials giving the...
  • WaPo: Hey, did you know Obama’s statements had expiration dates?

    12/16/2009 9:53:47 AM PST · by SeekAndFind · 12 replies · 749+ views
    Hotair ^ | 12/16/2009 | Ed Morrissey
    Guess who just discovered the Jim Geraghty Axiom? Dana Milbank of the Washington Post reports that Barack Obama reversed his get-tough-with-Big-Pharma routine when it came to actually, er, getting tough with Big Pharma. How did Obama’s allies on Capitol Hill feel about it? “Awkward”: On the campaign trail, Barack Obama vowed to take on the drug industry by allowing Americans to import cheaper prescription medicine. “We’ll tell the pharmaceutical companies ‘thanks, but no, thanks’ for the overpriced drugs — drugs that cost twice as much here as they do in Europe and Canada,” he said back then. On Tuesday, the...
  • Pharmaceutical deal holding up bipartisan health amendment

    12/10/2009 6:07:58 PM PST · by jazusamo · 8 replies · 427+ views
    The Hill ^ | December 10, 2009 | Jeffrey Young
    A deal between the White House and the pharmaceutical industry is holding up a bipartisan amendment to allow the importation of cheaper prescription drugs from abroad, according to a member of the Senate Democratic leadership. The Senate has been debating the amendment, sponsored by Sen. Byron Dorgan (D-N.D.), since Tuesday but has not held a vote, which is contributing to a stall in the floor action on healthcare reform. Dorgan’s measure, which would permit bulk exports of medicines from countries such as Canada, enjoys broad and bipartisan support and likely has the backing of more than 60 senators, which would...
  • Bitter Pills: Deal or No Deal Big Pharma Loses

    11/12/2009 7:06:22 AM PST · by grumpa · 2 replies · 495+ views
    National Review ^ | November 12, 2009 | Robert Costa
    This summer, just when the health-care debate grew sour, Big Pharma struck a sweet deal. Or so they thought. By agreeing to pony up $80 billion to support Obamacare, the Pharmaceutical Research and Manufacturers of America, or PhRMA, assumed that they dodged a bullet. Ladle the Democrats some cash now, they reckoned, and maybe they could avoid some big bills later.
  • Baucus Scores a Big Win for Big Pharma

    09/24/2009 6:53:44 PM PDT · by Saije · 4 replies · 453+ views
    Washington Independent ^ | 9/24/2009 | Mike Lillis
    In a major victory for the pharmaceutical industry, the Senate Finance Committee on Thursday shot down legislation to provide seniors full coverage through the controversial coverage gap in Medicare’s prescription drug benefit. The proposal, sponsored by Sen. Bill Nelson (D-Fla.), would have closed Medicare’s so-called “doughnut hole,” which forces millions of seniors each year to pay full prescription costs after annual expenses have reached a certain threshold. The Congressional Budget Office estimated this week that the proposal would save the government $106 billion over 10 years — enough to close the gap in coverage under Part D with $50 billion...
  • Pharma partly to blame for healthcare woes(country is in worse trouble than we thought)

    09/14/2009 11:14:43 PM PDT · by mtrott · 16 replies · 1,060+ views
    PharmaTimes ^ | 10 September 2009 | Katrina Megget
    As many as 84% of Americans blame the pharmaceutical industry for the country’s healthcare woes, a new survey has found. Results of The Harris Poll, held in August, show Americans blame many different parties for the problems of the current healthcare system in the USA, with pharma coming second in the blame game with 84% of adults pointing the finger at pharma. Even more than 50% believed the industry deserves a “great deal” of blame.
  • Air America Blasts Obama as a "Charming Liar" for Deal with Pharmaceutical Companies - Video 8/19/09

    08/20/2009 6:37:57 AM PDT · by Federalist Patriot · 15 replies · 1,168+ views
    Freedom's Lighthouse ^ | August 20, 2009 | BrianinMO
    Here is a new Naked Emperor News video that plays audio from the Left-Wing "Air America" Radio Network actually exposing President Barack Obama's "back room" deal with Big Pharmaceutical companies to support his ObamaCare plan. The Left is furious with Obama. In this audio, they say Obama is a "charming liar." A caller also says what Obama is doing is "fascist" because of the merging of political power with corporate power to impose their will on the nation. The audio is intermingled with flashbacks of Obama condeming the Pharmaceutical companies and saying he would be transparent in his administration. Interestingly,...
  • PhARMA In Bed With Obama Because They Want To STOP A Single-Payer System

    08/15/2009 12:51:38 PM PDT · by Starman417 · 5 replies · 761+ views
    Flopping Aces ^ | 08-15-09 | Curt
    Deputy Assistant Under-Minister of Truth Linda Douglass tried her best to dodge the questions from Wolf Blitzer regarding the 150 million dollars PhARMA is agreeing to pay for advertising to support ObamaCare socialism: BLITZER: Did PhRMA, in exchange, make a promise of $150 million to pay for advertising to help the president's plan go forward? DOUGLASS: What -- what you have, Wolf, is this deal that is $80 billion. And we are very pleased, obviously, that -- that the pharmaceutical industry agrees with us, that there's an urgent need for comprehensive health insurance reform that's going to protect Americans from...
  • Obama & PhARMA Make Secret Deal

    08/14/2009 7:44:12 AM PDT · by Starman417 · 28 replies · 841+ views
    Flopping Aces ^ | 08-14-09 | Curt
    You know the messiah is tumbling back to earth when HuffPo puts up a investigative post about the collusion between Obama and big Pharma: A memo obtained by the Huffington Post confirms that the White House and the pharmaceutical lobby secretly agreed to precisely the sort of wide-ranging deal that both parties have been denying over the past week. The memo, which according to a knowledgeable health care lobbyist was prepared by a person directly involved in the negotiations, lists exactly what the White House gave up, and what it got in return. It says the White House agreed to...
  • Internal Memo Confirms Big Giveaways In WH Deal With Pharma (HuffPo lefties turning on Obama)

    08/13/2009 4:35:31 PM PDT · by St. Louis Conservative · 11 replies · 949+ views
    The Huffington Post | August 13, 2009 | Ryan Grim
    Here's the link. In exchange, the Pharmaceutical Researchers and Manufacturers Association (PhRMA) agreed to cut $80 billion in projected costs to taxpayers and senior citizens over ten years. Or, as the memo says: "Commitment of up to $80 billion.. The health care lobbyist said that what deal still exists is uncertain, as a result of House pressure. "Now the White House is backing away from it, as you know, because of pressure from the House, because the House was not a party to the deal," he said. "The Speaker put enormous pressure on the White House, [saying], 'We weren't a...
  • Internal Memo Confirms Big Giveaways In White House Deal With Big Pharma

    08/13/2009 10:53:44 AM PDT · by Jim Robinson · 65 replies · 3,589+ views
    Huffington Post ^ | Aug 13, 2009 | By Ryan Grim
    A memo obtained by the Huffington Post confirms that the White House and the pharmaceutical lobby secretly agreed to precisely the sort of wide-ranging deal that both parties have been denying over the past week. The memo, which according to a knowledgeable health care lobbyist was prepared by a person directly involved in the negotiations, lists exactly what the White House gave up, and what it got in return. It says the White House agreed to oppose any congressional efforts to use the government's leverage to bargain for lower drug prices or import drugs from Canada -- and also agreed...
  • White House Affirms Deal on Drug Cost (the evil insurance companies didn't make a deal)

    08/06/2009 7:45:59 AM PDT · by reaganaut1 · 9 replies · 614+ views
    New York Times ^ | August 5, 2009 | David D. Kirkpatrick
    Pressed by industry lobbyists, White House officials on Wednesday assured drug makers that the administration stood by a behind-the-scenes deal to block any Congressional effort to extract cost savings from them beyond an agreed-upon $80 billion. Drug industry lobbyists reacted with alarm this week to a House health care overhaul measure that would allow the government to negotiate drug prices and demand additional rebates from drug manufacturers. In response, the industry successfully demanded that the White House explicitly acknowledge for the first time that it had committed to protect drug makers from bearing further costs in the overhaul. The Obama...
  • House Tri-Committee Bill Would Hurt Patients and Kill Jobs

    08/06/2009 12:58:04 PM PDT · by neverdem · 1 replies · 278+ views
    House Tri-Committee Bill Would Hurt Patients and Kill Jobs WASHINGTON, July 31 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement after the Energy and Commerce Committee mark-up of the House Tri-Committee bill: "PhRMA remains committed to working with the Administration and Congress to help enact comprehensive health care reform this year. Our policy agreement with the White House and the Senate Finance Committee, which provides $80 billion in meaningful cost-savings over 10 years, clearly demonstrates that commitment. We share the same goal of helping ensure that all Americans have access...
  • Help! I need input...

    06/30/2008 6:31:59 PM PDT · by pharmamom · 27 replies · 190+ views
    WhenWeAreQueen ^ | June 30, 2008 | pharmamom
    I would appreciate feedback on my site. Is it too female-oriented? Is it too over-the-top? I want a gun. Two guns, actually. I want a shotgun that makes that “ca-chick” sound that causes an intruder’s bowels to loosen, and I want an automatic handgun that I can keep in my purse (where rodent lovers keep their so-called dogs. And just what do they do if those…things…ate something disagreeable and have a blast of diarrhea while en suite?). And in happy coincidence, Justice Kennedy says that’s all right by him. I was waiting with worms on my tongue for the Erudite...
  • Wal-Mart cuts prices on more drugs Retailer adds a 90-day supply for $10

    05/05/2008 7:37:16 PM PDT · by RKBA Democrat · 43 replies · 113+ views
    Market Watch ^ | 5-5-08 | Andrea Cheng
    In another expansion of its prescription drug program that has helped to increase its pharmacy sales, Wal-Mart Stores Inc. said it's adding a 90-day supply of its prescription drugs for $10, increasing additional medications for women, and unveiling $4 over-the-counter medicines. Wal-Mart and its Sam's Club pharmacies will fill prescriptions for as many as 350 generic drugs costing $10 for a 90-day supply, an expansion from the existing 30-day supplies that cost $4. Wal-Mart also is adding $9 women's generic prescription drugs for up to a 30-day supply that are used to treat osteoporosis, breast cancer, menopause and hormone deficiency,...
  • Big Pharma opens wallet to Dems

    03/07/2008 12:03:29 PM PST · by BlazingArizona · 10 replies · 151+ views
    cnn.com ^ | 3/07/08 | Aaron Smith
    Democrats have long served as the traditional enemy of Big Pharma, but in this presidential campaign, the left is taking the lion's share of drugmaker money. Democratic senators Barack Obama and Hillary Clinton are the top recipients of donations from the pharmaceutical industry, according to The Center for Responsive Politics, a non-profit, non-partisan research group in Washington, D.C. Meanwhile, donations to Sen. John McCain, who was recently endorsed by President Bush as the official Republican candidate, pale in comparison.
  • Farmed-Out Pharma

    02/01/2008 4:54:34 PM PST · by grey_whiskers · 8 replies · 98+ views
    Forbes online ^ | 2-11-08 | Susan Kitchens
    In the race to find the next billion-dollar drug, some of the world's largest pharmaceutical companies are starting in China. For the past three years industry giants such as Pfizer and Merck have quietly dished out early-stage research projects to scientists working in the whitewashed buildings of WuXi PharmaTech, China's largest drug R&D company. "We have a cost advantage and access to other resources, such as research animals, and a very good infrastructure. All of these things make us competitive," says Hai Mi, head of WuXi's investor relations.
  • Data About Zetia Risks Was Not Fully Revealed

    12/22/2007 2:30:45 AM PST · by neverdem · 57 replies · 522+ views
    NY Times ^ | December 21, 2007 | ALEX BERENSON
    New evidence shows that the drug makers Merck and Schering-Plough have conducted several studies of their popular cholesterol medicine Zetia that raise questions about its risks to the liver, but the companies have never published those results. Partial results of the studies, alluded to in documents on the Food and Drug Administration’s Web site, raise questions about whether Zetia can cause liver damage when used long term with other cholesterol drugs called statins. Most of the millions of people who use Zetia take it along with a statin like Lipitor, Crestor or Zocor. Or they take it in a single...
  • Big Pharma and Big Brother join forces to drug children (April 2007)

    10/27/2007 6:18:43 PM PDT · by ddtorquee · 67 replies · 164+ views
    Douglas Report ^ | April 17, 2007 | Dr. Douglas
    Launched by an Executive Order in April of 2002 under the guise of expanding the scope of 1990's Americans with Disabilities Act (ADA), the New Freedom Commission on Mental Health has since received the official sanction of the U.S. Congress... This commission is the driving force behind a massive policy shift that will literally turn public schools into mental health screening centers...all parents of public school children are supposed to be receiving written notice of these new federally mandated mental health screening policies. Some will also get permission slips to sign that will allow school counselors or other non-medically-educated bureaucrats...
  • U.S. Senate OKs greater access to Canada drugs (But Bush vows to veto plan)

    05/07/2007 6:06:32 AM PDT · by Wolfie · 137 replies · 1,506+ views
    Winnipeg Sun ^ | May 4, 2007
    U.S. Senate OKs greater access to Canada drugs But Bush vows to veto plan WASHINGTON — The U.S. Senate is courting a presidential veto on prescription drug imports from Canada. The latest bid to legalize imports survived a major challenge yesterday in the upper house, where senators endorsed the idea by a vote of 63-28. But there will be other hurdles for the amendment allowing more access to lower-priced medicine from Canada, part of a broader bill related to the Food and Drug Administration. And even if it survives, President George W. Bush has vowed to veto the plan, also...
  • Brazil bypasses patent on U.S. AIDS drug

    BRASILIA, Brazil - President Luiz Inacio Lula da Silva took steps Friday to let Brazil buy an inexpensive generic version of an AIDS drug made by Merck & Co. despite the U.S. drug company's patent. Silva issued a "compulsory license" that would bypass Merck's patent on the AIDS drug efavirenz, a day after the Brazilian government rejected Merck's offer to sell the drug at a 30 percent discount, or $1.10 per pill, down from $1.57. The country was seeking to purchase the drug at 65 cents a pill, the same price Thailand pays. It was the first time Brazil has...
  • Brazil bypasses patent on U.S. AIDS drug

    BRASILIA, Brazil - President Luiz Inacio Lula da Silva took steps Friday to let Brazil buy an inexpensive generic version of an AIDS drug made by Merck & Co. despite the U.S. drug company's patent. Silva issued a "compulsory license" that would bypass Merck's patent on the AIDS drug efavirenz, a day after the Brazilian government rejected Merck's offer to sell the drug at a 30 percent discount, or $1.10 per pill, down from $1.57. The country was seeking to purchase the drug at 65 cents a pill, the same price Thailand pays. It was the first time Brazil has...
  • Big Pharma's Just Deserts?

    04/10/2007 8:35:48 PM PDT · by rellimpank · 3 replies · 442+ views
    American Spectator ^ | 10 Apr 07 | Doug Bandow
    The pharmaceutical companies are learning that sleeping with the government results in more than the one-night stand they desired. Legislation to impose price controls on pharmaceuticals purchased through the 2003 Medicare drug benefit will soon hit the Senate floor. Some drugmakers may have to learn a second time. Merck's early efforts to mandate use of its new human papillomavirus (HPV) vaccine could similarly backfire. What government gives with one hand it usually takes away with anothe
  • FDA Panel Advises Approval of Bird Flu Vaccine

    02/27/2007 5:22:27 PM PST · by khnyny · 7 replies · 269+ views
    Fox News ^ | 2/27/07 | AP
    WASHINGTON — Federal health advisers recommended Tuesday that the government approve the first bird flu vaccine as a stopgap measure, despite evidence it wouldn't protect most people. In separate votes, the outside panel said the vaccine was both safe and effective. A vaccine must meet both standards to win FDA approval. The votes came after Food and Drug Administration officials said the Sanofi Aventis SA vaccine still could play an important role in protecting against the increased likelihood of a pandemic, despite its limited effectiveness. "I am of the view that anything is better than nothing," said panel member Dr....
  • Drug Companies Look East (Big Pharma next to outsource jobs)

    01/16/2006 1:46:46 PM PST · by jb6 · 3 replies · 415+ views
    Red Herring ^ | January 16, 2006
    Less stringent regulations in Asian nations reduce the timeline for drug discovery. January 16, 2006 The drug discovery outsourcing market for India and China will grow 15.3 percent annually to $19.8 billion in 2011 from $7.3 billion in 2004, according to a report released Monday by the research firm Frost & Sullivan. With competition in the global market escalating, multinational companies are aggressively outsourcing their production facilities. Global pharmaceutical manufacturing was worth nearly $50 billion in 2004. India and China have the potential to garner about 35 to 40 percent of the outsourced market, said the report. The revenue forecasts...
  • Can Americans Trust Their Medicine?

    12/20/2004 8:25:05 PM PST · by jb6 · 6 replies · 426+ views
    TechNewsWorld ^ | December 20, 2004
    The FDA allowed Merck to claim that Vioxx was gentler on the stomach than naproxen, but many patients might be surprised to learn that Pfizer has never conclusively demonstrated the gastrointestinal superiority of Celebrex. For Susan Ferris, the drug Celebrex has been "a godsend." The 48-year-old South Florida woman has been taking it for her arthritis pain since 2001. She can't tolerate older remedies, such as aspirin or ibuprofen. Since Friday's announcement that Celebrex might be linked to heart attacks and strokes, though, she's not sure what to think. On top of that, she worries about her 58-year-old husband, who...
  • The Demonization of a Life-Saving Industry

    11/29/2004 11:51:02 AM PST · by softengine · 39 replies · 933+ views
    Intellectual Conservative ^ | 27 November 2004 | Dr. Elizabeth M. Whelan
    America's pharmaceutical industry is under attack. Critics have pejoratively nicknamed the industry "Big Pharma" (to conjure up an image of it being in a line-up next to "Big Tobacco") and characterize it as uncaring, duplicitous, profit-hungry and manipulative. The resentment of the industry is palpable -- whether in my own conversations with relatives and friends (particularly elderly and/or infirm ones) or in Congress, where advocates are demanding the legalization of drug importation from Canada and elsewhere in a desperate (and in the long run, futile) attempt to bring prices down. Perhaps nowhere does the strident criticism of the industry come...